All I am insinuating is that as a general rule the source of truth should be discoverable in the actual clinical record for each patient, if it is not in the Amarex database. I am not implying Cytodyn is pursuing that; they backed off the BLA due to the effort involved to set things right. I am an outsider looking in through a glass clouded and need the company to provide clarity…I will continue to wait with the rest of us as we don’t have any inside scoop, only conjecture.